NM_004643.4:c.18_23dupGGCGGC

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 8P and 2B. PP5_Very_StrongBP3BS2_Supporting

The NM_004643.4(PABPN1):​c.18_23dupGGCGGC​(p.Ala7_Ala8dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000032 in 1,155,620 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. A8A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000029 ( 0 hom. )

Consequence

PABPN1
NM_004643.4 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 2.81

Publications

1 publications found
Variant links:
Genes affected
PABPN1 (HGNC:8565): (poly(A) binding protein nuclear 1) This gene encodes an abundant nuclear protein that binds with high affinity to nascent poly(A) tails. The protein is required for progressive and efficient polymerization of poly(A) tails at the 3' ends of eukaryotic transcripts and controls the size of the poly(A) tail to about 250 nt. At steady-state, this protein is localized in the nucleus whereas a different poly(A) binding protein is localized in the cytoplasm. This gene contains a GCG trinucleotide repeat at the 5' end of the coding region, and expansion of this repeat from the normal 6 copies to 8-13 copies leads to autosomal dominant oculopharyngeal muscular dystrophy (OPMD) disease. Related pseudogenes have been identified on chromosomes 19 and X. Read-through transcription also exists between this gene and the neighboring upstream BCL2-like 2 (BCL2L2) gene. [provided by RefSeq, Dec 2010]
BCL2L2-PABPN1 (HGNC:42959): (BCL2L2-PABPN1 readthrough) This locus represents naturally occurring read-through transcription between the neighboring BCL2L2 (BCL2-like 2) and PABPN1 (poly(A) binding protein, nuclear 1) genes on chromosome 14. The read-through transcript encodes a fusion protein that shares sequence identity with each individual gene product. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PP5
Variant 14-23321471-T-TGGCGGC is Pathogenic according to our data. Variant chr14-23321471-T-TGGCGGC is described in ClinVar as Pathogenic. ClinVar VariationId is 280233.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP3
Nonframeshift variant in repetitive region in NM_004643.4
BS2
High AC in GnomAd4 at 8 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004643.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PABPN1
NM_004643.4
MANE Select
c.18_23dupGGCGGCp.Ala7_Ala8dup
disruptive_inframe_insertion
Exon 1 of 7NP_004634.1
PABPN1
NM_001360551.3
c.18_23dupGGCGGCp.Ala7_Ala8dup
disruptive_inframe_insertion
Exon 1 of 6NP_001347480.1
BCL2L2-PABPN1
NM_001387340.1
c.550-694_550-689dupGGCGGC
intron
N/ANP_001374269.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PABPN1
ENST00000216727.9
TSL:1 MANE Select
c.18_23dupGGCGGCp.Ala7_Ala8dup
disruptive_inframe_insertion
Exon 1 of 7ENSP00000216727.4
PABPN1
ENST00000397276.6
TSL:1
c.18_23dupGGCGGCp.Ala7_Ala8dup
disruptive_inframe_insertion
Exon 1 of 6ENSP00000380446.2
BCL2L2-PABPN1
ENST00000553781.5
TSL:2
c.433-694_433-689dupGGCGGC
intron
N/AENSP00000451320.1

Frequencies

GnomAD3 genomes
AF:
0.0000531
AC:
8
AN:
150644
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000289
AC:
29
AN:
1004976
Hom.:
0
Cov.:
31
AF XY:
0.0000273
AC XY:
13
AN XY:
476184
show subpopulations
African (AFR)
AF:
0.0000501
AC:
1
AN:
19974
American (AMR)
AF:
0.00
AC:
0
AN:
5794
Ashkenazi Jewish (ASJ)
AF:
0.0000942
AC:
1
AN:
10612
East Asian (EAS)
AF:
0.00
AC:
0
AN:
17698
South Asian (SAS)
AF:
0.0000528
AC:
1
AN:
18946
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
18118
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2592
European-Non Finnish (NFE)
AF:
0.0000286
AC:
25
AN:
873488
Other (OTH)
AF:
0.0000265
AC:
1
AN:
37754
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000531
AC:
8
AN:
150644
Hom.:
0
Cov.:
32
AF XY:
0.0000680
AC XY:
5
AN XY:
73536
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41178
American (AMR)
AF:
0.00
AC:
0
AN:
15150
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3456
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5138
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4790
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10110
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
67522
Other (OTH)
AF:
0.00
AC:
0
AN:
2076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
1

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2
Apr 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PABPN1: PM1:Strong, PM2, PP1:Moderate, PP4:Moderate, PS4:Moderate

May 24, 2018
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.18_23dupGGCGGC pathogenic variant in the PABPN1 gene has been reported previously in individuals with oculopharyngeal muscular dystrophy in four families (Brais et al., 1998). This duplication is in the region of the polyalanine tract in exon 1, and other duplications nearby have been reported in the Human Gene Mutation Database in association with oculopharyngeal muscular dystrophy (Stenson et al., 2014). The c.18_23dupGGCGGC variant causes an in-frame duplication of 2 alanine residues, denoted p.Ala10_Ala11dup. The result of this variant is a polyalanine tract length of 12 in this individual. The c.18_23dupGGCGGC variant was not observed in approximately 192 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.18_23dupGGCGGC as a pathogenic variant.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.8
Mutation Taster
=23/177
disease causing (ClinVar)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs193922941; hg19: chr14-23790680; API